These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 9234506)
1. HIV resources on the Web. Trends Microbiol; 1997 Jul; 5(7):267. PubMed ID: 9234506 [No Abstract] [Full Text] [Related]
2. New database. Vondrasek J; Wlodawer A Science; 1996 Apr; 272(5260):337-8. PubMed ID: 8602518 [No Abstract] [Full Text] [Related]
3. AIDS/HIV information database logs 120,000 requests in first months on Internet. AIDS Patient Care STDS; 1996 Feb; 10(1):56-7. PubMed ID: 11361678 [No Abstract] [Full Text] [Related]
4. Database of HIV proteinase structures. Vondrasek J; Wlodawer A Trends Biochem Sci; 1997 May; 22(5):183. PubMed ID: 9175479 [No Abstract] [Full Text] [Related]
5. Computer analysis of the conservation and uniqueness of ribozyme-targeted HIV sequences. DeYoung MB; Hampel A Methods Mol Biol; 1997; 74():27-36. PubMed ID: 9204417 [No Abstract] [Full Text] [Related]
6. Predicting drug-resistant mutations of HIV protease. Ishikita H; Warshel A Angew Chem Int Ed Engl; 2008; 47(4):697-700. PubMed ID: 18058968 [No Abstract] [Full Text] [Related]
7. UCSF creates Web site for information on HIV/AIDS. Am Fam Physician; 1997 Nov; 56(8):2132. PubMed ID: 9390102 [No Abstract] [Full Text] [Related]
8. Publicizing AIDS data early and often. Science; 1994 Aug; 265(5175):1023. PubMed ID: 8066438 [No Abstract] [Full Text] [Related]
9. Drug resistance of HIV-1 protease against JE-2147: I47V mutation investigated by molecular dynamics simulation. Bandyopadhyay P; Meher BR Chem Biol Drug Des; 2006 Feb; 67(2):155-61. PubMed ID: 16492163 [TBL] [Abstract][Full Text] [Related]
14. Database of three-dimensional structures of HIV proteinases. Vondrasek J; van Buskirk CP; Wlodawer A Nat Struct Biol; 1997 Jan; 4(1):8. PubMed ID: 8989313 [No Abstract] [Full Text] [Related]
15. Comparative studies on inhibitors of HIV protease: a target for drug design. Jayaraman S; Shah K In Silico Biol; 2008; 8(5-6):427-47. PubMed ID: 19374129 [TBL] [Abstract][Full Text] [Related]
16. Yeast two-hybrid assay for examining human immunodeficiency virus protease heterodimer formation with dominant-negative inhibitors and multidrug-resistant variants. Todd S; Laboissière MC; Craik CS Anal Biochem; 2000 Jan; 277(2):247-53. PubMed ID: 10625514 [TBL] [Abstract][Full Text] [Related]
17. Resources for HIV/AIDS on the Internet. Dewhurst S; Sander DM; Sgro JY Mol Med Today; 1996 Feb; 2(2):52-7. PubMed ID: 8796856 [No Abstract] [Full Text] [Related]
18. Insight into analysis of interactions of saquinavir with HIV-1 protease in comparison between the wild-type and G48V and G48V/L90M mutants based on QM and QM/MM calculations. Saen-oon S; Aruksakunwong O; Wittayanarakul K; Sompornpisut P; Hannongbua S J Mol Graph Model; 2007 Nov; 26(4):720-7. PubMed ID: 17543558 [TBL] [Abstract][Full Text] [Related]
19. Molecular dynamics and free energy studies on the wild-type and mutated HIV-1 protease complexed with four approved drugs: mechanism of binding and drug resistance. Alcaro S; Artese A; Ceccherini-Silberstein F; Ortuso F; Perno CF; Sing T; Svicher V J Chem Inf Model; 2009 Jul; 49(7):1751-61. PubMed ID: 19537723 [TBL] [Abstract][Full Text] [Related]
20. Evolutionary analysis of HIV-1 protease inhibitors: Methods for design of inhibitors that evade resistance. Stoffler D; Sanner MF; Morris GM; Olson AJ; Goodsell DS Proteins; 2002 Jul; 48(1):63-74. PubMed ID: 12012338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]